STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
Status:
Active, not recruiting
Trial end date:
2023-10-11
Target enrollment:
Participant gender:
Summary
This research study will test whether atorvastatin, a drug commonly prescribed for reducing
cholesterol levels, can protect the heart during chemotherapy with doxorubicin. Atorvastatin
is from a family of medications that are commonly called "statins"
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Brigham and Women's Hospital Dana-Farber Cancer Institute